""	"Rank"	"NCT.Number"	"Title"	"Status"	"Study.Results"	"Conditions"	"Interventions"	"Phases"	"Study.Type"	"Locations"	"URL"
"280"	280	"NCT04305106"	"Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT"	"Recruiting"	"No Results Available"	"COVID-19 Pneumonia"	"drug: bevacizumab"	"Not Applicable"	"Interventional"	"Qilu Hospital of Shandong University, Jinan, Shandong, China"	"https://ClinicalTrials.gov/show/NCT04305106"
"542"	542	"NCT04344782"	"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort"	"Not yet recruiting"	"No Results Available"	"COVID19 Pneumonia"	"drug: bevacizumab injection"	"Phase 2"	"Interventional"	""	"https://ClinicalTrials.gov/show/NCT04344782"
"935"	935	"NCT04275414"	"Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia"	"Recruiting"	"No Results Available"	"Coronavirus Infections"	"drug: bevacizumab injection"	"Phase 2|Phase 3"	"Interventional"	"Renmin Hospital of Wuhan University, Wuhan, Hubei, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Moriggia-Pelascini Gravedona Hospital, Gravedona, Italy"	"https://ClinicalTrials.gov/show/NCT04275414"
